Gastroloc DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30mg and Pantoprazole 40mg, designed for the effective management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, bloating, and gastric discomfort. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing symptomatic relief and promoting healing in acid-related conditions. This dual-action capsule is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, peptic ulcer disease, and functional dyspepsia where both acid suppression and prokinetic effects are beneficial. Gastroloc DSR is particularly useful in patients experiencing delayed gastric emptying alongside acid hypersecretion. The combination ensures enhanced therapeutic efficacy by addressing multiple pathophysiological mechanisms underlying upper gastrointestinal tract disorders. It is recommended to be taken orally as prescribed by a healthcare professional, with dosage adjustments based on clinical response and tolerability. Caution is advised in patients with known hypersensitivity to either component, and it should be used under medical supervision to monitor for potential adverse effects and drug interactions.